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Abstract
Pseudomonas aeruginosa and Aspergillus fumigatus are pathogens frequently co-inhabit-
ing immunocompromised patient airways, particularly in people with cystic fibrosis. Both
microbes depend on the availability of iron, and compete for iron in their microenvironment.
We showed previously that the P. aeruginosa siderophore pyoverdine is the main instru-
ment in battling A. fumigatus biofilms, by iron chelation and denial of iron to the fungus. Here
we show that A. fumigatus siderophores defend against anti-fungal P. aeruginosa effects.
P. aeruginosa supernatants produced in the presence of wildtype A. fumigatus planktonic
supernatants (Afsup) showed less activity against A. fumigatus biofilms than P. aeruginosa
supernatants without Afsup, despite higher production of pyoverdine by P. aeruginosa.
Supernatants of A. fumigatus cultures lacking the sidA gene (AfΔsidA), unable to produce
hydroxamate siderophores, were less capable of protecting A. fumigatus biofilms from P.
aeruginosa supernatants and pyoverdine. AfΔsidA biofilm was more sensitive towards inhib-
itory effects of pyoverdine, the iron chelator deferiprone (DFP), or amphothericin B than
wildtype A. fumigatus biofilm. Supplementation of sidA-deficient A. fumigatus biofilm with A.
fumigatus siderophores restored resistance to pyoverdine. The A. fumigatus siderophore
production inhibitor celastrol sensitized wildtype A. fumigatus biofilms towards the anti-fun-
gal activity of DFP. In conclusion, A. fumigatus hydroxamate siderophores play a pivotal role
in A. fumigatus competition for iron against P. aeruginosa.
Introduction
Ecosystems of pathogens have been described with regard to a multitude of diseases [1–3]. The
bacterium Pseudomonas aeruginosa and the fungus Aspergillus fumigatus form such an ecosys-
tem, e.g. when chronically colonizing the lungs of cystic fibrosis (CF) individuals [4–7]. Both
pathogens have been associated with deterioration of lung function [4–17], and their com-
bined presence in airways of CF patients seems to aggravate disease progression [18,19]. P.
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aeruginosa and A. fumigatus also are prominent opportunistic pathogens in immune-compro-
mised patients, particularly in those with neutropenia [20,21].
Previous studies have focused on A. fumigatus inhibition caused by P. aeruginosa products
such as pyocyanin (5-N-methyl-1-hydroxyphenazine) [22–25], 1-hydroxyphenazine
[22,24,25], phenazine-1-carboxamide and phenazine-1-carboxylic acid [25]. We recently
reported that the P. aeruginosa product pyoverdine is the major mediator of P. aeruginosa
inhibitory function towards A. fumigatus biofilms [26]. Pyoverdine, the major siderophore of
P. aeruginosa [27,28], strongly binds to iron, which is an essential co-factor for both P. aerugi-
nosa and A. fumigatus [29–31]. Pyoverdine-bound iron is no longer available for A. fumigatus,
starving A. fumigatus of iron, and resulting in fungistasis [26]. The question arose whether A.
fumigatus could counteract P. aeruginosa inhibition. Here we provide evidence that A. fumiga-
tus hydroxamate siderophores in times of iron shortage, created by a competing microbe,
ensure availability of the essential co-factor iron exclusively to the fungus. Concomitantly,
interference with A. fumigatus siderophore production renders the fungus more sensitive to
anti-fungal effects of iron chelators, and possibly more sensitive even to effects of anti-fungal
drugs not involved in iron chelation, like amphotericin B.
Materials and methods
Materials
Pyoverdine (PYOV), 3-hydroxy-1,2-dimethyl-4(1H)pyridine (deferiprone, DFP), celastrol,
2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide inner salt (XTT),
and menadione were purchased from Sigma-Aldrich (St. Louis, MO). Amphotericin B (AmB)
was derived from X-Gen Pharmaceuticals Inc. (Horseheads, NY). Chrome Azurol S (CAS)
was purchased from MP Biomedicals (Solon, OH). Ferri- and desferri-triacetylfusarinine C
(TAFC, DF-TAFC) were purified as described previously [32].
Isolates
All isolates used in this study are summarized in Table 1.
The work flow for the following procedures is summarized in S1 Fig.A.
fumigatus supernatant production
A. fumigatus conidia were inoculated into RPMI 1640 medium (RPMI, Lonza, Walkersville,
MD) at 2.5x104 conidia/ml. A. fumigatus suspensions were incubated at 37˚C for 48h
Table 1. Isolates used in this study.
Organism Isolate Description ATCC Reference
A. fumigatus 10AF Virulent patient isolate 90240 [33,34]
A. fumigatus AF13073 Parental strain for AfΔsidA 13073
A. fumigatus AfΔsidA L-ornithine-N 5-mono-oxygenase deficient A. fumigatus mutant strain [35]
A. fumigatus AF46645 Parental strain for AfΔsidC and AfΔsidF 46645
A. fumigatus AfΔsidC Deficient for the hydroxamate siderophores ferricrocin (FC) and hydroxy-FC (HFC) [36]
A. fumigatus AfΔsidF Deficient for the hydroxamate siderophores fusarinine C (FsC) and triacetylfusarinine C (TAFC). [36]
A. fumigatus AfS77 Derivate of ATCC 46645 [37]
P. aeruginosa PA14 Parental strain for pvdD- and pvdD-pchE- [38]
P. aeruginosa pvdD- Pyoverdine deficient mutant [39]
P. aeruginosa pvdD-pchE- Pyoverdine/pyochelin deficient mutant [26]
https://doi.org/10.1371/journal.pone.0216085.t001
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(S1 Fig). A. fumigatus supernatants (Afsup) were filtered (0.22 μm) for sterility after the
growth period.
Pseudomonas supernatant production and pyoverdine measurement
PA14 supernatants were prepared as detailed previously [40]. Briefly, P. aeruginosa [5 x 107
cells/ml] was inoculated into RPMI 1640 medium, or mixtures of RPMI and Afsup, and incu-
bated at 37˚C for 24h. Bacterial growth was measured at 600 nm with a spectrophotometer
(Genesys 20, Thermo Fisher Scientific Inc., Waltham, MA). Bacterial cultures were centrifuged
at 200 x g for 30 min at room temperature, and filtered (0.22 μm). Pyoverdine production in
the supernatant was measured as described previously [41] at 405 nm. Pyoverdine measure-
ments were normalized to bacterial growth using the formula: Relative PYOV expression =
OD405 / OD600. At the concentrations used in this study, pyoverdine, a colored substance,
did not interfere with the colorimetric XTT assay used for determination of fungal metabo-
lism. PYOV concentrations in undiluted P. aeruginosa supernatants are about 30 μM. Pyover-
dine concentrations in sputum have been shown to be between 0.3 and 51 μM [42].
Assay for the measurement of metabolism of A. fumigatus forming (BCAM
assay, Bioassay-Conidia-Agar-Metabolic) or preformed (BHAM assay,
Bioassay-Hyphae-Agar-Metabolic) biofilms
BCAM and BHAM assays were performed as described previously [26]. In these assays, A.
fumigatus grows out into biofilms covering the agar surface. Briefly, RPMI agar containing
2.5x104 to 105 A. fumigatus conidia/ml agar (as specified for different experiments in the
Results section) was distributed into sterile flat-bottom 96 well cell culture plates (COSTAR,
Corning, NY) at 100 μl/well. Upon agar solidification, wells were either incubated at 37˚C for
24 hours before loading (= BHAM assays), or immediately loaded with 100 μl of test sub-
stances (= BCAM assays). Control wells on each test plate contained 100 μl of RPMI 1640
medium, allowing the conversion of test results to % of the RPMI control (= 100%). Loaded
plates were incubated at 37˚C for 24 hours. Fungal metabolism was determined by XTT meta-
bolic assay at 490 nm [40,43]. Menadione (vitamin K3) was used as an ingredient in the XTT
metabolic assay, boosting the reduction of tetrazolium salts to formazans. XTT assays were
evaluated using a plate reader (Opsys MR, DYNEX Technologies, Chantilly, VA). Although
XTT is a measure of metabolic activity of cells, previous studies of A. fumigatus have indicated
that XTT results are linear with mass, and equated XTT result with dry weight [44–46].
Aspergillus growth assays
AfΔsidA (104conidia) was point-inoculated on 2 ml solid minimal medium [47] in the pres-
ence of 50–600 μl PA14 wildtype or PA14 PaΔpvdD bacterial supernatant with or without sup-
plementation of FeSO4 [1 μM]. Radial fungal growth was scored after incubation of the plates
for 48 hours at 37˚C.
Chrome azurol S (CAS) assay
For measurement of siderophore production 10x CAS assay reagent was prepared as described
previously [48]. One part 10x CAS reagent was combined with 9 parts Afsups in RPMI, and
incubated at 37˚C for 24 hours. Mixtures were measured using the plate reader, and compared
to RPMI not containing CAS reagent or RPMI/1x CAS reagent as reference points.
Aspergillus counter-balances Pseudomonas’ anti-fungal activity
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Statistical analysis
Results were analyzed using Student’s t test, if two groups were compared, and by 1-way
ANOVA, combined with a Tukey’s post-test for multiple comparisons. Data reported as per-
centages of the control value were compared after arcsin transformation of the proportions
[26]. All data in this study are expressed as a mean ± SD.The number of replicates in each
assay is four or higher. Assays were repeated at least twice, and a representative experiment is
shown. Supporting information on data sets used in this study is provided in S1 Table.
Results
A. fumigatus supernatants induce pyoverdine production by P. aeruginosa
Fungal supernatants (Afsup), produced by planktonic growth of A. fumigatus strain 10AF in
RPMI (experimental setup described in S1 Fig), induced pyoverdine production by P. aerugi-
nosa in a dose-dependent manner, with 10% Afsup still significantly inducing pyoverdine
production. As pyoverdine is induced in response to iron shortage, increased pyoverdine pro-
duction here suggests sequestration of iron from the growth medium by Afsup (Fig 1A).
Concentrations of Afsup higher than 10% interfered with bacterial growth in a concentra-
tion-dependent manner (Fig 1B). As iron is a major co-factor for microbial growth, the reason
for inhibitory effects of Afsup on P. aeruginosa growth might be a reaction to iron denial.
Although gliotoxin has been suggested as an anti-microbial factor [49], in our hands superna-
tants produced by an A. fumigatus mutant unable to produce gliotoxin [50] affected P. aerugi-
nosa growth to a similar degree as supernatants produced by its parent (S2 Fig). Distilled water
(25%), instead of Afsup (25%) during P. aeruginosa supernatant preparation did not result in
interference with P. aeruginosa effects on A. fumigatus biofilm metabolism, indicating that
P. aeruginosa supernatant dilution by Afsups was not the reason for the protective effects of
Afsups (S3 Fig).
In order to verify that Afsup indeed induced production of pyoverdine, we used a PA14
mutant not able to produce pyoverdine (PaΔpvdD) [39]. With or without the presence of
Afsup, PaΔpvdD supernatant did not absorb at 405 nm, confirming that Afsup did not induce
production of an unknown P. aeruginosa product detectable at 405 nm (S4A Fig).
Afsup protects A. fumigatus forming biofilm from P. aeruginosa anti-
fungal activity and pure pyoverdine
Pyoverdine has detrimental effects on Af biofilm metabolism [26]. Surprisingly, although con-
taining high concentrations of pyoverdine (Fig 1A), P. aeruginosa supernatants produced in
the presence of Afsup were less inhibitory for forming (Fig 1C) or preformed (Fig 1D) A. fumi-
gatus biofilms than P. aeruginosa supernatants produced without Afsups,whereas Afsups up to
50% did not affect A. fumigatus biofilms when administered alone. Similarly, when P. aerugi-
nosa supernatants and Afsups were prepared separately, their combination was less inhibitory
to A. fumigatus biofilms than P. aeruginosa supernatant alone (Fig 1E).
Presumably owing to their lack of pyoverdine production, supernatants of PaΔpvdD were
less inhibitory to 10AF biofilms than PA14 supernatants. The presence of Afsup further
decreased the inhibitory activity of PaΔpvdD supernatants to RPMI control levels (S4B Fig).
Protective Afsup effects were also observed when Afsups were combined with pure pyoverdine
(Fig 1F).
Taken together, these data indicate that despite its ability to induce pyoverdine production
by P. aeruginosa, Afsup protects A. fumigatus biofilms.
Aspergillus counter-balances Pseudomonas’ anti-fungal activity
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Stability of protective Af supernatant effects
In order to determine the reason for protection of A. fumigatus biofilms by Afsup, we first
tested stability of 10AFsup to heat, and long-term storage. 10AFsup was heated to 56˚C or
90˚C for 30 minutes, or subjected to three freeze-thaw cycles. Treated or untreated 10AFsups
were diluted to 25%, combined with P. aeruginosa supernatants, and tested for effects on A.
fumigatus biofilm metabolism. Our results show that heat does not destroy the protective com-
pound in Afsup (Fig 2A). Repeated freeze-thaw cycles diminished, but did not abolish protec-
tion (Fig 2A). We also kept 10AFsup at 4˚C for 12 months, and measured protection from
Fig 1. A. fumigatus supernatant effects on P. aeruginosa growth and pyoverdine production. Planktonic 10AF
supernatant (10AFsup) was diluted in RPMI from 50% to 0% 10AFsup, and incubated with P. aeruginosa cells (5x107/ml) at
37˚C for 24h. Relative pyoverdine (PYOV) concentrations (A) were calculated using the quotient A405 (PYOV)/A600
(bacterial growth: B). Supernatants shown in A and B, as well as PA14 supernatant not containing 10Afsup, were compared
with respect to their activities on 10AF forming biofilm (C: BCAM) or preformed biofilm (D: BHAM) metabolism. E: 10AF
forming biofilm was incubated with 10 or 25% PA14 wildtype supernatant with or without the addition of 25% 10AFsup for
24 hours. Effects on 10AF forming biofilm metabolism were evaluated by XTT assay. F: 10AF forming biofilm was incubated
with 5 or 10 μM pyoverdine (PYOV) with or without the addition of 25% 10AFsup for 24 hours. Effects on 10AF forming
biofilm metabolism were evaluated by XTT assay. Statistics for A and B: 1way ANOVA, RPMI (white bar) vs. all groups
containing Afsup (black bars). Statistics for C and D: 1way ANOVA, PA14 supernatant (white striped bar) vs. PA14
supernatant containing 10AFsup (grey striped bars). Other comparisons by t-Test as indicated by the ends of the brackets.
Statistics for E and F: t-Test, RPMI (white bar) vs. all other bars. Other comparisons as indicated by the ends of the brackets.
One, two or three asterisks = p� 0.05, p� 0.01 or p� 0.001, respectively.
https://doi.org/10.1371/journal.pone.0216085.g001
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pyoverdine every 3 months. The protective potential of Afsup was almost constant over the 12
months period (Fig 2B). When 10AFsup was kept at room temperature for 12 months, protec-
tion was marginally lower, but still significant (Fig 2B). Taken together, our data suggest that
the protective compound in 10AFsup is stable.
A. fumigatus siderophores protect A. fumigatus biofilm from P. aeruginosa
anti-fungal activity
Knowing that iron is a crucial factor for A. fumigatus biofilm, that pyoverdine inhibitory activ-
ity is owing to withholding iron from the fungus, and that the protective compound in Afsup
Fig 2. Stability of Afsup. A: Mixtures (25%) of freshly prepared 10AFsup in RPMI were kept at 4˚C, or heated to 56˚C
or 90˚C for 30 minutes, or subjected to 3 freeze-thaw cycles. Treated 10AFsups (25% in RPMI), were combined with
20% P. aeruginosa supernatants, and tested for effects on A. fumigatus forming biofilm metabolism. B: 10AFsup was
stored at 4˚C for up to 12 months, and tested for protective activity against 5 μM pyoverdine (PYOV) every 3 months.
A portion of the 10AFsup was stored at room temperature (RT), and tested after 12 months of storage. Protective
activity was tested using a BCAM assay. Statistics for A: t-Test, PA14 supernatant (grey bar) vs. all other bars. Other
comparisons as indicated by the ends of the brackets. � indicate significant increases, ■ indicate significant decreases.
Statistics for B: t-Test, pyoverdine (white striped bar) vs. all other bars. One, two or three asterisks or squares = p�
0.05, p� 0.01 or p� 0.001, respectively.
https://doi.org/10.1371/journal.pone.0216085.g002
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is stable (Fig 2), we investigated the hypothesis that the protective compound might be an A.
fumigatus siderophore. We produced supernatant of an A. fumigatus mutant lacking sidA, a
gene crucial for the production of all four hydroxamate siderophores (AfΔsidAsup), and com-
pared to wildtype Afsup, produced by the AfΔsidA parent AF13073 (AF13073sup). A CAS assay
confirmed the lack of siderophores in AfΔsidAsup (Fig 3A). Dilutions (25%) of AF13073sup
and AfΔsidAsup were incubated with PA14 or PaΔpvdD. AF13073sup stimulated pyoverdine
production by PA14 significantly more than AfΔsidA sup (Fig 3B). AfΔsidAsup also showed less
protection for A. fumigatus biofilm against P. aeruginosa anti-fungal activity than AF13073sup
(Fig 3C). When siderophore-deficient fungus was treated with pyoverdine, significant damage
was induced (Fig 3D), whereas Afsup derived from either 10AF or AF13073 wildtype strains
protected AfΔsidA from pyoverdine-induced damage (Fig 3D). It has to be noted that neither
the absence of pyoverdine nor the presence of Afsup from siderophore-deficient fungus pre-
vented P. aeruginosa anti-fungal activity completely.
In comparison to wildtype A. fumigatus, AfΔsidA has a growth disadvantage due to missing
Fe3+ uptake, which requires siderophores. 10AF or AF13073 wildtype supernatants, containing
siderophores and iron, partially compensated AfΔsidA disadvantages, as indicated by higher
XTT values for AfΔsidA in the presence of Afsups (Fig 3D). In conclusion, A. fumigatus sidero-
phores are able to protect A. fumigatus biofilms against P. aeruginosa anti-fungal activity. Fig
3C also shows that AfΔsidA sup was able to provide protection for A. fumigatus biofilm from
PaΔpvdD supernatant, whereas there was no protection against PA14 wildtype sup by either
Fig 3. A. fumigatus siderophores protect A. fumigatus biofilm from P. aeruginosa anti-fungal activity. A:
Planktonic supernatants produced by an A. fumigatus mutant lacking hydroxamate siderophore production (AfΔsidA)
or its parental strain (AF13073) were subjected to siderophore production measurement by CAS assay. B: RPMI, or
25% AfΔsidA or AF13073 supernatant in RPMI, were inoculated with PA14 wildtype or the PA14 mutant PaΔpvdD
[5x107 cells/ml], and incubated at 37˚C for 24h. Pyoverdine production was measured. C: Supernatants obtained in B
(middle and right sets of 3 bars), as well as 25% AfΔsidA or AF13073 supernatants in RPMI (left 3 bars) were tested for
activity against A. fumigatus biofilm formation. D: AfΔsidA forming biofilm was incubated with 5 μM pyoverdine
(PYOV) with or without the addition of 25% 10AFsup or AF13073sup for 24 hours. Effects on forming biofilm
metabolism were evaluated by XTT assay. Statistics: t-Test. Comparisons without brackets: B: RPMI vs. A. fumigatus
supernatants for each bacterial strain. C: RPMI vs. all other bars. D: RPMI (leftmost white bar) vs. all other bars. Other
comparisons as indicated by the ends of the brackets. � indicate significant decreases, ■ indicate significant increases.
One, two, or three asterisks or squares = p� 0.05, or p� 0.01, or p� 0.001, respectively.
https://doi.org/10.1371/journal.pone.0216085.g003
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Afsup. This finding indicates that A. fumigatus hydroxamate siderophores are crucial for pro-
tection from detrimental pyoverdine effects, but that Afsup seems to contain other compounds
which are able to protect A. fumigatus biofilm when the Pasup challenge lacks the powerful
inhibitor pyoverdine.
AfΔsidA is more sensitive to P. aeruginosa anti-fungal activity and
pyoverdine than its wildtype
AfΔsidA-derived supernatants were significantly less protective against pyoverdine than wild-
type supernatants (Fig 4A). AfΔsidA is lacking the intracellular hydroxamate siderophores
ferricrocin (FC) and hydroxy-ferricrocin (HFC), as well as the extracellular hydroxamate side-
rophores fusarinin C (FsC) and triacetylfusarinine C (TAFC). Using A. fumigatus mutants
with specific mutations in intracellular (AfΔsidC), or extracellular hydroxamate siderophores
(AfΔsidF), we found that a lack of extracellular siderophores significantly interfered with pro-
tection from pyoverdine by A. fumigatus supernatants (Fig 4A). Protective effects of AfΔsidF
sup were significantly higher than protective effects of AfΔsidA sup (Fig 4A), indicating that
there might be some contribution to protection by other molecules missing in AfΔsidA sup.
Fig 4A also shows that supernatants, derived from three different A. fumigatus wildtypes
(AF13073, AF46645, AfS77) protected forming biofilm of a fourth A. fumigatus wildtype
(10AF), indicating that protection is not strain specific.
PA14 supernatants, prepared in RPMI, as well as pure pyoverdine, were significantly more
inhibitory during the formation of A. fumigatus biofilms derived from AfΔsidA conidia than
they were for biofilms derived from AF13073 conidia (Fig 4B). A. fumigatus mutants lacking
either intracellular (AfΔsidC), or extracellular hydroxamate siderophores (AfΔsidF) showed
increased sensitivity to PA14 supernatants or pure pyoverdine, compared to their wildtype
AF46645 (Fig 4B). The loss of extracellular hydroxamate siderophores was more important for
sensitivity than the loss of intracellular hydroxamate siderophores (Fig 4B). Using pure TAFC,
or desferri-TAFC (DF-TAFC) we found complete protection from pyoverdine anti-fungal
activity (Fig 4C), confirming the importance for A. fumigatus siderophores for protection
from P. aeruginosa anti-fungal activity.
As observed in Fig 2, the protective compound in Afsup was stable to prolonged heat treat-
ment (90˚C, 30 min.). After being subject to the same treatment pure TAFC and DF-TAFC
still significantly protected from pyoverdine toxicity (S5 Fig), further supporting the assump-
tion that A. fumigatus siderophores are the protective compound in Afsup. It was also noted
that pyoverdine was heat stable (S5 Fig).
The absence of A. fumigatus hydroxamate siderophores might have
therapeutic relevance
Compared to wildtype A. fumigatus (AF13073), AfΔsidA growth on plate was more affected
with the highest concentration (600 μl) of PA14 supernatant blocking growth (Fig 5A). Like-
wise, the IC50 of pyoverdine for AF13073-derived forming biofilm was about 4 times higher
than the IC50 for AfΔsidA-derived forming biofilm (Fig 5B). Recently, the iron chelator deferi-
prone (DFP), which similar to pyoverdine, exerts anti-fungal activity by denying iron from A.
fumigatus biofilms, has been proposed to be useful in anti-fungal therapy [51,52]. We tested
effects of DFP on AfΔsidA, or its wildtype, and found significantly higher sensitivity of A. fumi-
gatus biofilms to DFP when siderophore production was missing (Fig 5C). Genetic inhibition
of siderophore production also increased anti-fungal effects of amphotericin B (AmB), an
anti-fungal agent used against serious fungal infections, not only by Aspergillus, but also by
other fungi [53], on A. fumigatus forming biofilm metabolism (Fig 5D).
Aspergillus counter-balances Pseudomonas’ anti-fungal activity
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Fig 4. AfΔsidA is more sensitive towards PA14 or pure pyoverdine than its wildtype. A: Mixtures (25%) of freshly
prepared AF13073, AfΔsidA, AF46645, AfΔsidC, AfΔsidF, or AfS77 supernatants were combined with pyoverdine
[10 μM], and tested for effects on 10AF forming biofilm metabolism. Fungal metabolism was measured by XTT assay.
Measurements for controls (no pyoverdine) in each group were regarded as 100%. Statistics: t-Test, for each group: no
pyoverdine (grey bar) vs. pyoverdine (black bar). Other comparison as indicated by the ends of the bracket. B:
AF13073, AfΔsidA, AF46645, AfΔsidC, AfΔsidF or AfS77 BCAM assays were incubated with either RPMI, PA14
supernatant, or 5 μM pyoverdine. Fungal metabolism was measured by XTT assay. For each fungus RPMI control
measurements were regarded as 100%. Statistics: t-Test, comparison: RPMI (white bars) vs. PA14 supernatant (grey
bars), or pyoverdine (black bars) for each fungus. Other comparisons as indicated by the ends of the brackets. C: A
10AF BCAM assay was incubated with either RPMI, pyoverdine [10 μM], TAFC [5 or 10 μM], DF-TAFC [5 or 10 μM],
or combinations of pyoverdine and TAFC or DF-TAFC. Fungal metabolism was measured by XTT assay. RPMI
control measurements were regarded as 100%. Statistics: t-Test, comparison: RPMI (white bar) vs. all other bars. Other
comparisons as indicated by the ends of the brackets. One, two or three asterisks = p� 0.05, p� 0.01 or p� 0.001,
respectively.
https://doi.org/10.1371/journal.pone.0216085.g004
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Fig 5. Absence of hydroxamate siderophores sensitizes A. fumigatus. A: RPMI was inoculated with PA14 [5x107
cells/ml], incubated for 24 hours, and the culture supernatant was sterile filtered. Growth of point inoculated AF13073
or AfΔsidA (104conidia) on 3 ml solid minimal medium in the presence of 1 μM FeSO4 plus 50–600 μl of the sterile
filtered supernatants was compared after incubation for 48 h at 37˚C. B: AfΔsidA (white bars) or AF13073 (black bars)
BCAM assays were incubated with either RPMI or different concentrations of pyoverdine. Fungal metabolism was
measured by XTT assay. Statistics: t-Test. For each fungus RPMI controls were regarded as 100%. RPMI controls for
each fungus vs. all pyoverdine concentration. Other comparisons as indicated by the ends of the brackets. C: Wildtype
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As a pharmacological complementation of our data obtained using AfΔsidA, we investi-
gated effects of the SidA-biosynthesis inhibitor celastrol [54]. Celastrol showed anti-fungal
activity when used alone at concentrations above 5 μM (Fig 6). When combined with DFP,
celastrol significant enhanced anti-fungal effects by DFP (Fig 6).
Discussion
Fungal and bacterial biofilms e.g. frequently found co-inhabiting lungs of persons suffering
from cystic fibrosis, represent a potentially severe pathogenicity factor. The present study
mainly focuses on events during formation of A. fumigatus biofilm. In previous studies [40]
and in studies by many others, it has been shown that biofilm formation by A. fumigatus is
substantial within the first 16 hours of incubation. We have also performed many of the studies
described in the present communication against fully formed A. fumigatus biofilms that
develop over the subsequent 24 hours of incubation, and found the same phenomena,
although to a lesser degree than in the earlier phase of A. fumigatus biofilm formation, as illus-
trated in Fig 1C vs. 1D. This may suggest that iron is more important for the initial develop-
ment of A. fumigatus biofilms.
The human body contains free iron levels of 10−24 M [55]. Free iron levels are decreased
during infections due to increased levels of ferritin and the release of lactoferrin from neutro-
phils [56]. In the lungs of cystic fibrosis patients, P. aeruginosa and A. fumigatus, which both
are crucially dependent on the availability of free iron for metabolism and growth, aggravate
disease pathology [4–7]. Under low iron conditions, these organisms are forced to compete for
resources in the same environment [29,30].
As summarized in Fig 7, for P. aeruginosa as well as A. fumigatus a lack of iron is the signal
to increase production of siderophores [27,28]. Siderophores specifically chelate ferric iron
with a high affinity [57]. Siderophores are of different types, based on the way the iron is
(AF13073) or AfΔsidA forming biofilms were incubated with DFP [0.125–2 mM] at 37˚C for 24 hour. Fungal
metabolism was measured by XTT assay. Statistics: t-Test, RPMI vs. all other bars of the same group. Other
comparisons as indicated by the ends of the brackets. D: Wildtype (AF13073) or AfΔsidA forming biofilms were
incubated with AmB [19–312 ng/ml] at 37˚C for 24 hour. Fungal metabolism was measured by XTT assay. Statistics: t-
Test, RPMI vs. all other bars of the same group. Other comparisons as indicated by the ends of the brackets. One, two
or three asterisks = p� 0.05, p� 0.01 or p� 0.001, respectively.
https://doi.org/10.1371/journal.pone.0216085.g005
Fig 6. Celastrol sensitizes A. fumigatus for anti-fungal activity of DFP. Forming wildtype A. fumigatus biofilm
(10AF) was incubated with 1, 2.5, or 5 μM celastrol, 0.25–1 mM of DFP, or combinations of these two substances at
37˚C for 24 hour. Fungal metabolism was measured by XTT assay. Statistics: t-Test. Bars without DFP (leftmost group)
vs. all other bars with the same celastrol concentration. Other comparisons as indicated by the ends of the brackets.
One, two or three asterisks = p� 0.05, p� 0.01 or p� 0.001, respectively.
https://doi.org/10.1371/journal.pone.0216085.g006
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complexed: phenolate-, catecholate-, hydroxamate-, carboxylate-, or mixed type of sidero-
phores have been described [58].
The P. aeruginosa siderophore pyoverdine is a composite (mixed) siderophore comprising
a peptide chain and a chromophore [59]. Pyoverdines bind iron with very high affinity, are
able to acquire iron from transferrin, and their production is absolutely needed in mouse pul-
monary infections [60–62]. We have described pyoverdine to be the Pseudomonas-derived key
inhibitor of A. fumigatus in their intermicrobial competition via iron sequestration under low
iron conditions [26]. We note that the loss of pyoverdine did not prevent P. aeruginosa anti-
fungal activity completely, however. Pyochelin, the second siderophore of P. aeruginosa, is pro-
duced by all P. aeruginosa isolates, but its affinity for iron is much lower compared to pyover-
dine [63,64]. Pyoverdine does not act as a xenosiderophore for A. fumigatus [26], thus
withholding iron from the fungus, and inducing anti-fungal effects [26]. P. aeruginosa does
not seem to be able to use A. fumigatus siderophores either. Our results show that Afsups pro-
voke increased pyoverdine production by P. aeruginosa, indicating that there is a paucity of
iron in the medium. If P. aeruginosa could use iron bound to A. fumigatus siderophores, there
would be an abundancy of iron available to the bacterium, and hence no increase in pyover-
dine production. We here for the first time provide evidence that A. fumigatus is able to use
iron bound to its hydroxamate siderophores as the main defense against P. aeruginosa compe-
tition for iron. These findings are summarized in Fig 7. Our results using A. fumigatus mutants
defective in hydroxamate siderophore production also indicate that additional defense mecha-
nisms might be in place, since supernatants derived from these mutants still partially protected
from P. aeruginosa toxicity. Other microorganisms have developed defense mechanisms
against P. aeruginosa not based on protective siderophore production. Candida albicans
appears to defend itself against P. aeruginosa in part by down-regulating P. aeruginosa sidero-
phore production [65].
Fig 7. Summary. In need for iron P. aeruginosa (Pa) produces its siderophore pyoverdine (PYOV). PYOV-chelated
iron is not available to A. fumigatus (Af), resulting in iron deficiency and damage to the fungus. Anti-fungal activity in
part is counter-balanced by SidA-dependent A. fumigatus hydroxamate siderophores, providing iron to the fungus,
further denying iron from P. aeruginosa.
https://doi.org/10.1371/journal.pone.0216085.g007
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Anti-bacterial A. fumigatus supernatant effects as a reason for protective effects against P.
aeruginosa anti-fungal activity are highly unlikely. In the presence of Afsup, P. aeruginosa is
able to even produce more pyoverdine, which requires functional bacterial metabolism. Also,
Afsup protects from P. aeruginosa supernatants produced without Afsup being present, and
Afsup, as well as pure A. fumigatus siderophores, protect from pure pyoverdine. Additionally,
Afsups derived from a giotoxin mutant affected bacterial growth To the same degree as wild-
type Afsups. The most plausible explanation for anti-bacterial effects of Afsups is depletion of
essential factors in the medium, especially that of iron.
To overcome iron starvation, A. fumigatus produces its own siderophores [35]. A. fumiga-
tus is able to produce four hydroxamate-containing siderophores: ferricrocin (FC) as well as
hydroxyferricrocin (HFC) for intracellular iron trafficking, and fusarinine C (FsC) as well as
its derivative triacetylfusarinine C (TAFC) for extracellular iron scavenging [36,66,67]. The
first step in the biosynthesis of all four hydroxamate-containing siderophores is catalyzed by
the enzyme L-ornithine N5-monooxygenase, termed SidA [30,67]. SidA catalyzes oxygen and
NADPH-dependent hydroxylation of L-ornithine to N5-L-hydroxyornithine, a crucial step for
the biosynthesis of hydroxamate-containing siderophores [35]. In a similar fashion to P. aeru-
ginosa siderophores, A. fumigatus siderophores are essential for pathogenesis, as the AfΔsidA
strain is unable to establish invasive aspergillosis in a mouse model [35,56]. We show that in
contrast to wildtype A. fumigatus supernatants, supernatants derived from AfΔsidA were
unable to protect A. fumigatus biofilms from detrimental effects of P. aeruginosa supernatants,
or pyoverdine. This finding indicates the relevance of A. fumigatus siderophores for protection
of A. fumigatus from P. aeruginosa-induced iron denial, and was supported by our finding that
A. fumigatus siderophores (FC as well as TAFC) each could partially protect A. fumigatus from
detrimental P. aeruginosa effects (Fig 4A and 4B). Pure preparations of the sideropore TAFC
protected A. fumigatus from pyoverdine, even after heat treatment (Fig 4C, and S5 Fig). Pro-
tection by TAFC and its desferri form DF-TAFC was about equal, indicating that TAFC very
efficiently binds free iron in medium, before pyoverdine can do the same. TAFC-bound iron
does not seem to be transferable to pyoverdine, and exclusively is available to A. fumigatus.
A. fumigatus lacking hydroxamate siderophores, especially of the extracellular type, was
more susceptible to pyoverdine (Fig 4B). The most pronounced detrimental effects of pyover-
dine were observed when all four siderophores were missing.
A lack of siderophores, especially owing to a loss in SidA, renders the fungus more sensitive
to iron denial by either pyoverdine (Fig 5B), or the clinically used iron chelator deferiprone
(DFP, Fig 5B). Siderophore deficiency even sensitized the fungus to effects of amphotericin B
(AmB, Fig 5C). While sensitization to DFP might be expected knowing that iron chelation by
pyoverdine powerfully inhibits the fungus, sensitization to AmB is more surprising. It might
be that a struggle for iron takes away energy from the fungus, and dampens intrinsic defense
mechanisms, or that the membrane action of AmB [53] may adversely affect iron flux in the
fungus.
As a pharmacological analog to sidA knockout we used celastrol treatment [54]. Celastrol, a
pentacyclic triterpenoid that belongs to the family of quinone methides, exerts potent anti-can-
cer and anti-metastatic [68,69], anti-inflammatory [70,71], and antioxidant [72] activities.
Recently celastrol was identified as a noncompetitive inhibitor of SidA production [54]. Inhibi-
tion of SidA production by celastrol is detrimental to A. fumigatus growth [54]. We observed
inhibitory effects of celastrol on A. fumigatus metabolism as well (Fig 6). Since celastrol has
numerous effects [68–71] it can’t be excluded that effects on A. fumigatus are not solely owed
to inhibition of siderophores production.
SidA-deficiency or addition of celastrol to A. fumigatus wildtype cultures resulted not only
in reduced fungal growth [54], and reduced A. fumigatus biofilm metabolism (Fig 6), but also
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in increased sensitivity towards the iron chelator DFP. DFP is clinically used to treat iron over-
load, as in thalassemia major [73], but also interferes with iron needs of bacteria [74], and A.
fumigatus biofilms [51]. Given that celastrol does not have unwanted effects on the host it
might be quite useful in supporting anti-fungal therapy.
Previous studies have focused on P. aeruginosa products and their inhibition of A. fumiga-
tus, at high P. aeruginosa product concentrations. Such studies have not considered the possi-
ble response of A. fumigatus at the onset of P. aeruginosa competition. We here show that A.
fumigatus uses its siderophores to counter-balance iron denial by P. aeruginosa. In vivo, the
winning microbe in this competition might be the one which unleashes its products first, and
in the greatest quantity. A. fumigatus siderophores seem to also strengthen the fungus against
certain types of therapy. Therefore, interference with siderophore production might boost
existing therapy against A. fumigatus.
Supporting information
S1 Fig. Overview of the experimental setup. Af: Aspergillus fumigatus; Afsup: planktonic A.
fumigatus supernatant, Pa: Pseudomonas; Pasup: planktonic P. aeruginosa supernatant, PYOV:
pyoverdine;
(TIF)
S2 Fig. Gliotoxin content in Afsup is not likely to affect P. aeruginosa. P. aeruginosa cells (5
x 107 /ml) were incubated with planktonic supernatants (25%) derived from AF5322 wildtype,
AFgliΔP (gliotoxin mutant), or AFgliPR (reversion of the gliotoxin mutant) at 37˚C for 24h.
Bacterial growth (A600: A), and pyoverdine (PYOV; A405) were measured, and relative pyo-
verdine concentration (B) was calculated using the quotient A405/A600. Statistics by t-Test:
PA14 supernatant, not containing Afsup (white bar) vs. PA14 supernatants containing Afsup.
Two or three asterisks = p� 0.01 or p� 0.001, respectively.
(TIF)
S3 Fig. Reduction of nutrients affects bacterial growth, but does not result in protection of
A. fumigatus from P. aeruginosa toxicity. P. aeruginosa cells (5 x 107 /ml) were incubated in
RPMI 1640 medium containing 25% 10AFsup, or 25% sterile water, at 37˚C for 24h. A: Bacte-
rial growth (A600) was measured. Supernatants derived from A were tested for toxicity against
A. fumigatus biofilm formation (XTT assay: B). Statistics by t-Test: A: PA14 supernatant pre-
pared without Afsup or water addition (white bar) vs all other bars. B: RPMI (while bar) vs. all
other bars. Other comparisons as indicated by the ends of the brackets. Two or three
asterisks = p� 0.01 or p� 0.001, respectively.
(TIF)
S4 Fig. Afsup induces pyoverdine and protects from P. aeruginosa anti-fungal activity. A:
RPMI was inoculated with PA14 wildtype or the PA14 mutant PaΔpvdD (5x107 cells/ml), with
(black bars) or without (white bars) the presence of 25% 10AFsup, and incubated at 37˚C for
24h. Pyoverdine production was measured. B: Samples produced in A were used in a BCAM
assay, and compared to metabolism of 10AF forming biofilm in the presence of RPMI or 25%
10AFsup, incubated without bacteria. Statistics: t-Test, as indicated by the ends of the brackets.
Two or three asterisks = p� 0.01 or p� 0.001, respectively.
(TIF)
S5 Fig. TAFC and DF-TAFC are stable to prolonged heat treatment. A 10AF BCAM assay
was incubated with RPMI, TAFC [10 μM], DF-TAFC [10 μM], either fresh or heat treated
(90˚C for 30 min), and combined with pyoverdine (not heated) [PYOV, 10 μM]. Fungal
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metabolism was measured by XTT assay. Control (RPMI incubation without heat treatment)
was regarded as 100%. Statistics: t-Test, comparison: PYOV without heat treatment vs. all
other PYOV-containing bars. Other comparisons as indicated by the ends of the brackets.
One, two or three asterisks = p� 0.05, p� 0.01 or p� 0.001, respectively. Comparison of heat
treatment of PYOV to unheated PYOV is also shown.
(TIF)
S1 Table. Data sets used in this study.
(PDF)
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